Previous 10 | Next 10 |
- Adjournment solely to vote on Delaware reincorporation Proposal 3(a) - - Both leading independent advisory firms have issued favorable recommendations on proposal - WIXOM, Mich., June 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” ...
WIXOM, Mich., May 29, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic kidney disease...
The iShares Russell 2000 ETF ( IWM ) tracks a basket of small-cap stocks including companies not typically part of large-cap broad market indexes like the S&P 500. Year to date, the ETF is up 15%, but still 10% below its all-time high set in August of 2018, which is in contrast to the S&am...
Canopy Growth (NYSE: CGC ) initiated with Buy rating at Alliance Global Partners. More news on: Canopy Growth Corporation, Tilray, Inc., Rockwell Medical, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
The following slide deck was published by Rockwell Medical, Inc. in conjunction with their 2019 Q1 earnings Read more ...
Rockwell Medical, Inc. (RMTI) Q1 2019 Results Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Judy DiClemente – Investor Relations Stuart Paul – President and Chief Executive Officer Angus Smith – Chief Financial Officer Conference Cal...
Rockwell Medical (NASDAQ: RMTI ): Q1 GAAP EPS of -$0.15. Revenue of $15.56M (+4.4% Y/Y) Press Release More news on: Rockwell Medical, Inc., Earnings news and commentary, Healthcare stocks news,
WIXOM, Mich., May 09, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic ...
Biotech Stocks: Global Revenues For Ophthalmology Market Projected To Reach $26 Billion By 2022 May 9, 2019 Palm Beach, FL –May 9, 2019 – As the baby boomer generation ages, there is an increased need… no… a demand by these aging patients to avert vision and...
In my previous article I outlined reasons Rockwell Medical ( RMTI ) was worth considering as a speculative investment. Since then, Rockwell's risk could decrease significantly if the CMS approves a separate J-code for powdered Triferic as announced. If approved, dialysis centers - that are...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...